Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity

被引：0
作者：
Thierry Trenque
Elise Lepoix
Agathe Trenque
Aurore Morel
Brahim Azzouz
机构：
[1] Reims University Hospital,Department of Pharmacovigilance and Pharmacoepidemiology
[2] Avenue du General Koenig,undefined
[3] University of Reims Champagne-Ardenne,undefined
来源：
European Journal of Clinical Pharmacology | 2022年 / 78卷
关键词：
Pembrolizumab; Safety; Immune necrotizing myopathy; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 690
页数：3
相关论文
共 48 条
[21]  
De Bleecker JL(undefined)undefined undefined undefined undefined-undefined
[22]  
Day JA(undefined)undefined undefined undefined undefined-undefined
[23]  
Limaye V(undefined)undefined undefined undefined undefined-undefined
[24]  
Möhn N(undefined)undefined undefined undefined undefined-undefined
[25]  
Beutel G(undefined)undefined undefined undefined undefined-undefined
[26]  
Gutzmer R(undefined)undefined undefined undefined undefined-undefined
[27]  
Ivanyi P(undefined)undefined undefined undefined undefined-undefined
[28]  
Satzger I(undefined)undefined undefined undefined undefined-undefined
[29]  
Skripuletz T(undefined)undefined undefined undefined undefined-undefined
[30]  
Villadolid J(undefined)undefined undefined undefined undefined-undefined
12345